Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor IXa

Structure

Volumn 17, Issue 12, 2009, Pages 1669-1678

  Zögg, Thomas ^a   Brandstetter, Hans ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

Author keywords

PROTEINS; SIGNALING

Indexed keywords

BLOOD CLOTTING FACTOR 9A;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVATION; ENZYME KINETICS; ENZYME STRUCTURE; ENZYME SUBSTRATE; ENZYME SYNTHESIS; MUTANT; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID CHLOROMETHYL KETONES; AMINO ACID MOTIFS; BINDING SITES; CALCIUM; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; CYSTEINE ENDOPEPTIDASES; ETHYLENE GLYCOL; FACTOR IXA; FACTOR VIIIA; HUMANS; HYDROGEN BONDING; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MUTANT PROTEINS; NEOPLASM PROTEINS; PROTEIN CONFORMATION; SODIUM;

EID: 71049163438     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2009.10.011     Document Type: Article

References (56)

1. Adler M., Davey D.D., Phillips G.B., Kim S.H., Jancarik J., Rumennik G., Light D.R., and Whitlow M. Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa. Biochemistry 39 (2000) 12534-12542
2. Amphlett G.W., Kisiel W., and Castellino F.J. The interaction of Ca2+ with human Factor IX. Arch. Biochem. Biophys. 208 (1981) 576-585
3. Bajaj S.P., Sabharwal A.K., Gorka J., and Birktoft J.J. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain. Proc. Natl. Acad. Sci. USA 89 (1992) 152-156
4. Bajaj S.P., Schmidt A.E., Mathur A., Padmanabhan K., Zhong D., Mastri M., and Fay P.J. Factor IXa:factor VIIIa interaction. helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa. J. Biol. Chem. 276 (2001) 16302-16309
5. Bode W., Mayr I., Baumann U., Huber R., Stone S.R., and Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 8 (1989) 3467-3475
6. Brandstetter H., Bauer M., Huber R., Lollar P., and Bode W. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc. Natl. Acad. Sci. USA 92 (1995) 9796-9800
7. Brandstetter H., Kuhne A., Bode W., Huber R., von der Saal W., Wirthensohn K., and Engh R.A. X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition. J. Biol. Chem. 271 (1996) 29988-29992
8. Brünger A.T. Version 1.2 of the crystallography and NMR system. Nat. Protoc. 2 (2007) 2728-2733
9. Byrne R., Link R.P., and Castellino F.J. A kinetic evaluation of activated bovine blood coagulation factor IX toward synthetic substrates. J. Biol. Chem. 255 (1980) 5336-5341
10. Castillo M.J., Kurachi K., Nishino N., Ohkubo I., and Powers J.C. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X. Biochemistry 22 (1983) 1021-1029
11. CCP4 (Collaborative Computational Project, Number 4). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50 (1994) 760-763
12. Cho K., Tanaka T., Cook R.R., Kisiel W., Fujikawa K., Kurachi K., and Powers J.C. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates. Biochemistry 23 (1984) 644-650
13. Dang Q.D., and Di Cera E. Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases. Proc. Natl. Acad. Sci. USA 93 (1996) 10653-10656
14. DeLano W.L. The case for open-source software in drug discovery. Drug Discov. Today 10 (2005) 213-217
15. Eigenbrot C., Kirchhofer D., Dennis M.S., Santell L., Lazarus R.A., Stamos J., and Ultsch M.H. The factor VII zymogen structure reveals reregistration of beta strands during activation. Structure 9 (2001) 627-636
16. Enfield D.L., and Thompson A.R. Cleavage and activation of human factor IX by serine proteases. Blood 64 (1984) 821-831
17. Fay P.J., and Koshibu K. The A2 subunit of factor VIIIa modulates the active site of factor IXa. J. Biol. Chem. 273 (1998) 19049-19054
18. Fujikawa K., Legaz M.E., Kato H., and Davie E.W. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). Biochemistry 13 (1974) 4508-4516
19. Gandhi P.S., Chen Z., Mathews F.S., and Di Cera E. Structural identification of the pathway of long-range communication in an allosteric enzyme. Proc. Natl. Acad. Sci. USA 105 (2008) 1832-1837
20. Gopalakrishna K., and Rezaie A.R. The influence of sodium ion binding on factor IXa activity. Thromb. Haemost. 95 (2006) 936-941
21. Harding M.M. Geometry of metal-ligand interactions in proteins. Acta Crystallogr. D Biol. Crystallogr. 57 (2001) 401-411
22. Harding M.M. Metal-ligand geometry relevant to proteins and in proteins: sodium and potassium. Acta Crystallogr. D Biol. Crystallogr. 58 (2002) 872-874
23. Hopfner K.P., Brandstetter H., Karcher A., Kopetzki E., Huber R., Engh R.A., and Bode W. Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants. EMBO J. 16 (1997) 6626-6635
24. Hopfner K.P., Lang A., Karcher A., Sichler K., Kopetzki E., Brandstetter H., Huber R., Bode W., and Engh R.A. Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding. Structure 7 (1999) 989-996
25. Huntington J.A., Read R.J., and Carrell R.W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407 (2000) 923-926
26. Josso F., and Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb. Diath. Haemorrh. Suppl. 17 (1965) 35-44
27. Kolkman J.A., and Mertens K. Insertion loop 256-268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII. Biochemistry 39 (2000) 7398-7405
28. Kurachi K., and Davie E.W. Isolation and characterization of a cDNA coding for human factor IX. Proc. Natl. Acad. Sci. USA 79 (1982) 6461-6464
29. Lefkowitz J.B., Nuss R., Haver T., Jacobson L., Thompson A.R., and Manco-Johnson M. Factor IX Denver, ASN 346→ASP mutation resulting in a dysfunctional protein with defective factor VIIIa interaction. Thromb. Haemost. 86 (2001) 862-870
30. Lenting P.J., ter Maat H., Clijsters P.P., Donath M.J., van Mourik J.A., and Mertens K. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme. J. Biol. Chem. 270 (1995) 14884-14890
31. Leslie A.G.W. Newsl. Protein Crystallogr. 26 (1992)
32. Lindquist P.A., Fujikawa K., and Davie E.W. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom. J. Biol. Chem. 253 (1978) 1902-1909
33. Lollar P., Parker C.G., Kajenski P.J., Litwiller R.D., and Fass D.N. Degradation of coagulation proteins by an enzyme from Malayan pit viper (Akistrodon rhodostoma) venom. Biochemistry 26 (1987) 7627-7636
34. Mathur A., Zhong D., Sabharwal A.K., Smith K.J., and Bajaj S.P. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X. J. Biol. Chem. 272 (1997) 23418-23426
35. McRae B.J., Kurachi K., Heimark R.L., Fujikawa K., Davie E.W., and Powers J.C. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates. Biochemistry 20 (1981) 7196-7206
36. Morita T., Isaacs B.S., Esmon C.T., and Johnson A.E. Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid. J. Biol. Chem. 259 (1984) 5698-5704
37. Mukherjee S., Mukhopadhyay A., Chaudhuri K., and Ray K. Analysis of haemophilia B database and strategies for identification of common point mutations in the factor IX gene. Haemophilia 9 (2003) 187-192
38. Mutucumarana V.P., Duffy E.J., Lollar P., and Johnson A.E. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study. J. Biol. Chem. 267 (1992) 17012-17021
39. Neuenschwander P.F., Branam D.E., and Morrissey J.H. Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity. Thromb. Haemost. 70 (1993) 970-977
40. Osterud B., and Rapaport S.I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc. Natl. Acad. Sci. USA 74 (1977) 5260-5264
41. Page M.J., and Di Cera E. Role of Na+ and K+ in enzyme function. Physiol. Rev. 86 (2006) 1049-1092
42. Prasad S., Wright K.J., Banerjee Roy D., Bush L.A., Cantwell A.M., and Di Cera E. Redesigning the monovalent cation specificity of an enzyme. Proc. Natl. Acad. Sci. USA 100 (2003) 13785-13790
43. Reitter S., Streif W., Schabetsberger T., Wozak F., Hartl H., Male C., Muntean W., and Pabinger I. Austrian Hemophilia Registry: design, development and set of variables. Wien. Klin. Wochenschr. 121 (2009) 196-201
44. Rezaie A.R., Neuenschwander P.F., Morrissey J.H., and Esmon C.T. Analysis of the functions of the first epidermal growth factor-like domain of factor X. J. Biol. Chem. 268 (1993) 8176-8180
45. Schärer K., Morgenthaler M., Paulini R., Obst-Sander U., Banner D.W., Schlatter D., Benz J., Stihle M., and Diederich F. Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of Factor Xa bound to a quaternary ammonium ion ligand. Angew. Chem. Int. Ed. Engl. 44 (2005) 4400-4404
46. Schmidt A.E., Padmanabhan K., Underwood M.C., Bode W., Mather T., and Bajaj S.P. Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human activated protein C (APC). Sodium ion in the APC crystal structure is coordinated to four carbonyl groups from two separate loops. J. Biol. Chem. 277 (2002) 28987-28995
47. Schmidt A.E., Stewart J.E., Mathur A., Krishnaswamy S., and Bajaj S.P. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding. J. Mol. Biol. 350 (2005) 78-91
48. Sichler K., Banner D.W., D'Arcy A., Hopfner K.P., Huber R., Bode W., Kresse G.B., Kopetzki E., and Brandstetter H. Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions. J. Mol. Biol. 322 (2002) 591-603
49. Sichler K., Kopetzki E., Huber R., Bode W., Hopfner K.P., and Brandstetter H. Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop. J. Biol. Chem. 278 (2003) 4121-4126
50. Sippl M.J., and Wiederstein M. A note on difficult structure alignment problems. Bioinformatics 24 (2008) 426-427
51. Stürzebecher J., Kopetzki E., Bode W., and Hopfner K.P. Dramatic enhancement of the catalytic activity of coagulation factor IXa by alcohols. FEBS Lett. 412 (1997) 295-300
52. Turk, D. (1992). Doctoral Thesis (Technische Universität München).
53. Underwood M.C., Zhong D., Mathur A., Heyduk T., and Bajaj S.P. Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human coagulation factor xa. Studies on catalytic efficiency and inhibitor binding. J. Biol. Chem. 275 (2000) 36876-36884
54. Vagin A.A., and Teplyakov A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30 (1997) 1022-1025
55. van Dieijen G., Tans G., Rosing J., and Hemker H.C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J. Biol. Chem. 256 (1981) 3433-3442
56. Zögg T., and Brandstetter H. Activation mechanisms of coagulation factor IX. Biol. Chem. 390 (2009) 391-400